Merck’s $11.3 Billion Bio-Techne Deal Signals Growth in Precision Medicine
German pharmaceutical big Merck has introduced an settlement to accumulate U.S.-based biotechnology firm Bio-Techne in a deal valued at roughly $11.3 billion, marking one of many largest life sciences acquisitions…